Jaideep Vaidya, a distinguished professor at Rutgers Business School, was recently inducted by the American Institute for Medical and Biological Engineering (AIMBE) to its College of Fellows. The ...

FIU professors Angela Laird and Jorge Riera Diaz were recently inducted into the 2024 Class of the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows. Election to the ...

This fund supports numerous advancements related to health, energy and the environment. The Chemical and Biological Engineering Department—part of the School of Engineering and Applied Sciences—is an ...

The Department of Chemical and Biological Engineering at Northwestern University is pioneering transformational discoveries in synthetic biology, biotechnology, catalysis, medicine, complex systems, ...

Karin Wuertz-Kozak, a faculty researcher at Rochester Institute of Technology, was recently inducted into the American Institute for Medical and Biological Engineering (AIMBE) College of Fellows.

The Department of Chemical and Biological Engineering is updating one of its undergraduate majors to offer students greater flexibility in exploring biological engineering-focused courses. Starting in ...

The Department of Chemical and Biological Engineering at Northwestern University is pioneering transformational discoveries in synthetic biology, biotechnology, medicine, complex systems, energy, ...

STARKVILLE, Miss.—Alex Thomasson, professor and head of Mississippi State’s Department of Agricultural and Biological Engineering, is joining the prestigious International Academy of Agricultural and ...

Biomedical engineers have demonstrated a new synthetic approach that turbocharges bacteria into producing more of a specific protein, even proteins that would normally destroy them, such as ...

Ready to create the future of science? Join us. Study biomedical research, pharmaceuticals, renewable energy, materials science and more. Apply by January 15. Chemical engineers shape the future of a ...

Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir (LEN), a groundbreaking twice-yearly injectable HIV-1 capsid inhibitor for ...

High-quality HIV antigens for cutting-edge solutions. On February 18, 2025, Gilead Sciences (CA, US) announced a significant milestone: the US FDA accepted their New Drug Applications (NDAs) for ...